Hope in sight: A new imaging technique could detect eye disease before if affects vision.
Technology Review

Biomedicine

Detecting Eye Disease Early

A new technique could be used to diagnose and treat patients before they begin to go blind.

  • Wednesday, March 5, 2008
  • By Anna Davison

State-of-the-art imaging equipment is being used by researchers at the University of Michigan to spy on cells in the eye in order to detect eye disease at a very early stage. They say that their technique could pick up signs of serious problems, such as glaucoma, early enough for patients to be treated before their vision is affected.

The researchers' method looks for metabolic changes in the cells of the retina and optic nerve due to disease. Those effects begin long before the first obvious signs normally hit, such as vision loss or structural abnormalities.

Using a sophisticated camera system coupled with customized imaging software, the researchers were able to detect changes in the eyes of patients with a brain disorder that can affect the optic nerve, and in people with glaucoma and diabetic retinopathy, two of the most common causes of blindness.

"We believe that this is going to be useful in a variety of diseases that affect the eye," says Victor Elner, an ophthalmologist and pathologist at the University of Michigan. The new test takes less than six minutes, and Elner says that it could be developed as a "point and shoot" system in which images are analyzed on a computer, either in an ophthalmologist's office or at a centralized location.

Advertisement

If the technique proves effective, "it could provide an early warning that cells have become sick," says Joseph Rizzo, a neuro-ophthalmologist at the Massachusetts Eye and Ear Infirmary, who was not involved in the work. That would allow physicians to start aggressive treatment before patients begin to go blind. If they are treated early, progressive eye diseases like glaucoma can be controlled, which slows or prevents damage to the eye and preserves vision. "It's potentially truly wonderful," Rizzo says of the detection technique.

In a study reported in the current issue of Archives of Ophthalmology, Elner and four colleagues at the University of Michigan tested their imaging technique on six women who had recently been diagnosed with a condition called pseudotumor cerebri (PTC), a disorder in which a buildup of pressure in the brain causes symptoms similar to those of a brain tumor. In some PTC patients, pressure on the optic nerve can lead to vision loss.

The researchers began by administering standard vision tests to the women. They all had good visual acuity. Visual field testing, which measures the area seen by the eye and is routinely used to screen for diseases like glaucoma, indicated subtle abnormalities in some of the women.

Print

Related Articles

Gene Therapy for Eye Diseases

A new method could help macular degeneration patients avoid regular injections into the eye.

Restoring Sight

Gene therapy to make cells sensitive to light takes a step toward clinical use.

A Drug-Dispensing Lens

A startup company is developing contact lenses that deliver medications directly to the eye.

Close Comments

To comment, please sign in or register

Forgot my password

reed

2 Comments

  • 1441 Days Ago
  • 03/05/2008

The publication

http://archopht.ama-assn.org/cgi/content/short/126/2/259


Archives of Opthalmology
Vol. 126 No. 2, February 2008

Flavoprotein Autofluorescence Detection of Early Ocular Dysfunction

Victor M. Elner, MD, PhD; Seung Park, MD; Wayne Cornblath, MD; Richard Hackel, BA; Howard R. Petty, PhD

Arch Ophthalmol. 2008;126(2):259-260.

Metabolic stress occurs at disease onset and causes altered flavoprotein redox activity that increases flavoprotein autofluorescence (FA). Using a new method to measure ocular FA, we studied women with subtle visual dysfunction due to pseudotumor cerebri. Each FA value was greater in the more affected eye of each woman with pseudotumor cerebri, permitting identification of that eye in each case. Flavoprotein autofluorescence values averaged 60% greater in more affected eyes of women with pseudotumor cerebri, but not between eyes of healthy women (control subjects). These results demonstrate the clinical utility of FA and may permit early detection and monitoring of retinal and optic nerve diseases.

Reply

Advertisement

MAGAZINE

Can We Build Tomorrow's Breakthroughs?

Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.

Videos

The Virtual Nurse Will See You Now

More

Advertisement

Technology Review Lists

TR50

Our list of the 50 most innovative companies, including the following:

Apple

PrimeSense

IBM

Calxeda

More

Advertisement

Facebook

Advertisement